You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

March 3, 2017

What Is a Patent Worth?

Bangkok Post, Corporate Counsellor Column

When deciding how much to invest in their intellectual property rights, product manufacturers often ask, “What is a patent worth?” This is a reasonable question, given the costs required to obtain patent protection. But manufacturers need to understand that unless a product with high value and risk of being imitated is patent-protected, the product owner could lose potential profits by not possessing exclusive rights to the product. Investing in a patent will help protect you and your investors, and enable you to produce and sell your product, while preventing others from doing the same.

A patent is a limited monopoly right granted under the authority of the government, which will issue a patent for an invention that is a new, useful, and unobvious product or process, or an improvement on such an existing product or process. A patent lasts for 20 years from the date of application filing. The rights to a patent are granted in exchange for a complete and enabling disclosure or description of the best mode of implementing the invention.

Once you are granted a patent, it is the government’s obligation to prevent others from making, using, selling, or importing your invention. During this 20-year period, once the patent is approved and remains validly registered, you can go to court and obtain damages against any infringers of your patent, and in most circumstances, apply for an injunction to prevent ongoing infringement of your patent during the term of validity.

Valuing Your Patent

So what does this mean for the value of a patent? You may look at the profits that you currently earn on the sales of your product and ask yourself, “Would I lose my profits if I do not have a patent?” This lets you quantify, in monetary terms, what the patent may be worth. By reevaluating this amount each year for the remaining life of the patent, you will be able to generally determine the value of your patent.

A patent is necessary and has a value only when a product or process covered by the patent currently exists or will exist in the market. This concept also extends to improvements or upgrades to your invention, because if you do not obtain a patent for these items, then your competitor might. If they possess such a patent and you do not, then you may be unable to sell your improved or upgraded product or process in the future.

Licensing

When you own a patent, you can make the products protected by the patent and prevent others from doing so. But beyond this, you can also license or sell your patent, which further qualifies it as a valuable asset. For example, if someone were to make a claim for infringement against you, you could offer to cross-license your patent, or you could counterclaim or countersue based on your patent. In this instance, having multiple patents or building a patent portfolio can be a very profitable business model.

Valuation Methods

When you are looking to license or sell your patent, you will need to have a starting point for negotiations by determining the value of the patent. In general, you can assess the patent’s value in a couple of different ways—one of which is the “calculated value.” There are several different methodologies that you can employ to derive a calculated value, such as the cost method, market method, and income method, which are based on discounted cash flow. Then there are more sophisticated methodologies, such as the probability adjusted income method, Monte Carlo analysis, and binomial lattices and real options method. There is no shortage of methodologies that can be applied. These models allow a patent owner to draw an estimate of the value of the patent.

Another, less formal, method involves the “story” value. There can be either a good story behind a patented invention or an unattractive story. In discussions between a patent owner and any potential buyers, the story—or reasons behind why the owner is selling the patent—will have an effect on the ultimate value received for the patent from the buyer.

There is also the element of competition among potential buyers who wish to obtain your patent to consider. If several well-funded companies are competing to obtain your patent, or even if there is only one company that is highly motivated in acquiring it, then your patent obviously commands a high valuation.

As the patent owner, you may be a brilliant innovator, who has spent the past 20 years working very hard on an invention, which grew in value over time. But if you are a poor negotiator, you could destroy much of the value of your invention when you license your patent. Thus, savvy negotiating skills are key to maximize the desired amount of value you want from your patent.

RELATED INSIGHTS​ 

February 25, 2026
Tilleke & Gibbins has updated the Vietnam chapter in the newly released Licensing 2026 guide, published by Lexology Panoramic. The comparative guide provides companies and other interested readers with information on licensing law and practice in various countries around the world. Licensing 2026 provides detailed information on the following topics: Restrictions, laws and licensing arrangements Intellectual property issues: Paris Convention for the Protection of Industrial Property, contesting the validity of licensor’s IP rights, invalidity and expiry of IP rights, security interests, proceedings against third parties, sublicensing, jointly owned IP, first to file, scope of patent protection, trade secrets, copyright Software licensing: Perpetual licensing, legal requirements, user restrictions Royalties and payments, currency conversion, and taxes: Relevant legislation, restrictions, taxation of foreign licensors Competition law issues: Restrictions on trade, legal restrictions, and IP-related court rulings Indemnification, disclaimers, and damages: Prevalence and enforceability of indemnity provisions and contractual waivers of damages Termination: Right to terminate, impact of termination Bankruptcy: Impact of licensee or licensor bankruptcy Dispute resolution: Governing law, arbitration, enforceability, injunctive relief, contractual waivers The Vietnam chapter is available below as a PDF. Readers can gain 30 days of complementary access to the full Licensing 2026 guide and the rest of Lexology Panoramic’s varied offerings through this link.
January 30, 2026
On December 26, 2025, the government of Vietnam promulgated Decree No. 341/2025/ND-CP on administrative sanctions for violations of copyright and related rights (Decree 341), with an effective date of February 15, 2026. The new decree replaces Decree No. 131/2013/ND-CP, as amended, and represents the first comprehensive revision of the administrative enforcement framework in this area in eight years. Legislative Context and Objectives Decree 341 reflects Vietnam’s evolving copyright and related-rights framework, particularly in light of the country’s commitments under bilateral, regional, and multilateral treaties governing the digital environment. While the decree retains a number of provisions from the previous regime, it also introduces significant amendments to infringing acts, penalty thresholds, remedial measures, and enforcement procedures. The primary objectives of the new decree are to (i) enhance the deterrent effect of administrative sanctions; (ii) harmonize sanctions with the 2025 amendments to the Law on Intellectual Property and criminal law principles; and (iii) address enforcement challenges arising from online and cross-border exploitation of copyrighted works. Expanded Scope of Sanctionable Subjects Under Decree 341, administrative sanctions apply not only to Vietnamese entities committing infringing acts within Vietnam, but also to Vietnamese and foreign entities that commit acts of infringement on the internet where the protected content is accessed, consumed, or exploited by users in Vietnam. This expansion reflects the realities of cross-border digital exploitation. However, the decree does not yet provide precise definitions of key terms such as “users” or “consumers” of digital content in Vietnam, which may require further regulatory clarification. Monetary Penalties and Penalty Structure The statutory maximum fines remain unchanged, at VND 250 million for individuals and VND 500 million for organizations, but the penalty framework is substantially restructured. Fines are now calibrated based on three core criteria: (i) the amount of illegal profit obtained; (ii) the level of
January 30, 2026
Vietnam’s Intellectual Property (IP) Law, despite being amended in 2022, underwent another significant revision at the end of 2025. The latest amendment aimed to address five major policy objectives set by the Vietnamese government, including promoting innovation, digital transformation, and international integration. Among the most notable changes in the 2025 IP Law, which takes effect on 1 April 2026, is the expansion of industrial design protection under Article 4.13. The revised definition now includes partial designs and intangible designs, marking a transformative shift in Vietnam’s industrial design regime. This change has particularly significant implications on designs classified under Class 32 of the Locarno Classification—which covers graphic designs, logos, ornamentation, surface patterns, arrangements, and other intangible products. These designs, previously excluded from protection in Vietnam, are now recognized under the new legal framework. Background: Status of Class 32 Designs Before 2026 Th Intellectual Property Office of Vietnam currently applies the 13th edition of the Locarno Classification for industrial design filings. However, not all classes in this system have historically been eligible for protection. Under the 2022 IP Law, Class 32 designs were explicitly excluded based on the following legal grounds: Definition under Article 4.13 (2022 IP Law): “An industrial design is the external appearance of a product or a component for assembly into a complex product, expressed in shapes, lines, colors, or a combination thereof, and visible during the exploitation of the product’s utility or the complex product.” Product requirements under Article 21.2 of Circular 23/2023/TT-BKHCN: A product is defined as an object, a tool, a device, or means, manufactured by industrial or handicraft methods, with clear structure and function. A component for assembly into a complex product must be capable of independent circulation and detachable from the complex product. Based on these definitions, Class 32 designs, such as graphical
December 30, 2025
The Intellectual Property Office of Vietnam (IP Office), with support from the Japan International Cooperation Agency (JICA), is drafting additional annexes to its Guidelines for Patent Examination, focusing on the examination of patent applications in the pharmaceutical and biotechnology sectors. The new annexes are expected to be officially issued in early 2026 as Annexes III and IV, following the successful issuance in 2023 of Annexes I and II addressing computer program-related inventions. The IP Office recently organized a seminar to gather feedback on the draft annexes from intellectual property representatives, academic institutions, research institutes, and other interested parties, emphasizing its intention to receive further constructive opinions to refine the guidelines for pharmaceuticals and biotechnology. Why These Guidelines Matter Patent examination in Vietnam has traditionally relied on the Guidelines for Patent Examination issued under Decision No. 487/QD-SHTT (2010), recently supplemented by Annexes I and II. While these documents provide a solid foundation, they do not fully address practical challenges in examining pharmaceutical and biotech inventions, particularly issues related to clarity, sufficiency of disclosure, enablement, features of function and utility, combination therapies, and inventions involving artificial intelligence (AI) applications in these fields. Annexes III and IV aim to close these gaps by introducing structured principles and illustrative examples. Guidance on Patent Specification Requirements Annex III provides detailed guidance on the requirements for patent specifications in pharmaceuticals and biotechnology, covering two main parts: Part A addresses sufficiency of disclosure, clarity of specifications, and consistency between claims and descriptions. Part B covers inventions related to Markush-type compounds, claims containing exclusion statements (disclaimers), and additional experimental data submitted during examination. The Guidelines outline specific disclosure requirements for subject matters such as compounds, formulations, pharmaceutical compositions, genes, polypeptides, proteins, vectors, transgenic organisms, modified organisms, and hybrid cells. Annex III emphasizes that disclaimers are not accepted